These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
973 related items for PubMed ID: 24994869
1. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops. Jee D, Park SH, Kim MS, Kim EC. Invest Ophthalmol Vis Sci; 2014 Jul 03; 55(8):5081-9. PubMed ID: 24994869 [Abstract] [Full Text] [Related]
2. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome. Jee D, Park M, Lee HJ, Kim MS, Kim EC. J Cataract Refract Surg; 2015 Apr 03; 41(4):756-63. PubMed ID: 25487027 [Abstract] [Full Text] [Related]
3. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Hwang HS, Sung YM, Lee WS, Kim EC. Cornea; 2014 Sep 03; 33(9):935-41. PubMed ID: 25055152 [Abstract] [Full Text] [Related]
4. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS, Ji YS, Yoon KC. Cornea; 2014 Sep 03; 33(9):946-51. PubMed ID: 24915018 [Abstract] [Full Text] [Related]
5. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Kim EC, Choi JS, Joo CK. Am J Ophthalmol; 2009 Feb 03; 147(2):206-213.e3. PubMed ID: 18848318 [Abstract] [Full Text] [Related]
6. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness. Hommer A, Schmidl D, Kromus M, Bata AM, Fondi K, Werkmeister RM, Baar C, Schmetterer L, Garhöfer G. Eur J Ophthalmol; 2018 Jul 03; 28(4):385-392. PubMed ID: 29592773 [Abstract] [Full Text] [Related]
7. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Am J Ophthalmol; 2007 Jul 03; 144(1):86-92. PubMed ID: 17493572 [Abstract] [Full Text] [Related]
8. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye. Perényi K, Dienes L, Kornafeld A, Kovács B, Kiss HJ, Szepessy Z, Nagy ZZ, Barsi Á, Acosta MC, Gallar J, Kovács I. J Ocul Pharmacol Ther; 2017 Jul 03; 33(6):487-492. PubMed ID: 28375789 [Abstract] [Full Text] [Related]
10. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. Salib GM, McDonald MB, Smolek M. J Cataract Refract Surg; 2006 May 03; 32(5):772-8. PubMed ID: 16765793 [Abstract] [Full Text] [Related]
11. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride]. He H, Liu ZG, Lin ZR, Liu XC, He H, Xiao QG. Zhonghua Yan Ke Za Zhi; 2012 Jan 03; 48(1):33-40. PubMed ID: 22490914 [Abstract] [Full Text] [Related]
12. Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study. Nebbioso M, Evangelista M, Librando A, Plateroti AM, Pescosolido N. Biomed Pharmacother; 2013 Sep 03; 67(7):659-63. PubMed ID: 23906760 [Abstract] [Full Text] [Related]
13. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye. Byun YJ, Kim TI, Kwon SM, Seo KY, Kim SW, Kim EK, Park WC. Cornea; 2012 May 03; 31(5):509-13. PubMed ID: 19730097 [Abstract] [Full Text] [Related]
14. Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins. Giménez-Gómez R, García-Catalán MR, Gallardo-Galera JM. Arch Soc Esp Oftalmol; 2013 Mar 03; 88(3):88-91. PubMed ID: 23473084 [Abstract] [Full Text] [Related]
15. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Benelli U, Nardi M, Posarelli C, Albert TG. Cont Lens Anterior Eye; 2010 Apr 03; 33(2):61-7. PubMed ID: 20153684 [Abstract] [Full Text] [Related]
16. Evaluation of the clinical course of dry eye syndrome. Horwath-Winter J, Berghold A, Schmut O, Floegel I, Solhdju V, Bodner E, Schwantzer G, Haller-Schober EM. Arch Ophthalmol; 2003 Oct 03; 121(10):1364-8. PubMed ID: 14557170 [Abstract] [Full Text] [Related]
17. Comparison of autologous serum eye drops with different diluents. Cho YK, Huang W, Kim GY, Lim BS. Curr Eye Res; 2013 Jan 03; 38(1):9-17. PubMed ID: 22928476 [Abstract] [Full Text] [Related]
18. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review. Ribeiro MVMR, Barbosa FT, Ribeiro LEF, Sousa-Rodrigues CF, Ribeiro EAN. Arq Bras Oftalmol; 2019 Sep 09; 82(5):436-445. PubMed ID: 31508669 [Abstract] [Full Text] [Related]
19. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye. Hongyok T, Chae JJ, Shin YJ, Na D, Li L, Chuck RS. Arch Ophthalmol; 2009 Apr 09; 127(4):525-32. PubMed ID: 19365035 [Abstract] [Full Text] [Related]
20. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Cömez AT, Tufan HA, Kocabıyık O, Gencer B. Curr Eye Res; 2013 Nov 09; 38(11):1095-103. PubMed ID: 23841565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]